Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

3.3K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

197
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
197
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

1000
Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1000

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study.

JMIR research protocols·2026
Same author

Neighborhood-Level Racial and Ethnic Residential Segregation and Incidence of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Journal of the American Heart Association·2026
Same author

Pharmacoequity and the Promise of GLP-1 Therapies in Cardiovascular Disease.

Circulation·2026
Same author

Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes.

JAMA·2026
Same author

Real-Time Benefit Tools in 2026-More Work Is Needed.

JAMA network open·2026
Same author

Antihypertensive Medication Use and Prescription Discontinuation Among Postpartum Women.

American journal of hypertension·2026

Related Experiment Video

Updated: Oct 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K

Identifying outcome measures for atrial fibrillation value-based contracting using the Delphi method.

Elizabeth C S Swart1, Chester B Good2, Rochelle Henderson3

  • 1UPMC Centers for High-Value Health Care and Value-Based Pharmacy Initiatives, UPMC Health Plan, Pittsburgh, PA, USA.

Research in Social & Administrative Pharmacy : RSAP
|November 12, 2021
PubMed
Summary
This summary is machine-generated.

Preventing stroke is the top outcome for atrial fibrillation medication value-based contracts. Stakeholders prioritized stroke prevention and feasible data collection for contract design.

Keywords:
Atrial fibrillationDelphi methodOutcome measuresPharmaceutical value-based contracting

More Related Videos

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.5K

Related Experiment Videos

Last Updated: Oct 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.5K

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Clinical Outcomes Research

Background:

  • Value-based contracts link pharmaceutical payments to predefined health outcomes.
  • These contracts aim to enhance value through shared risk and aligned incentives between manufacturers and payers.

Purpose of the Study:

  • To identify key outcomes for value-based contracts (VBCs) for atrial fibrillation (AF) medications.
  • To achieve consensus among diverse stakeholders on the most meaningful and feasible outcomes for AF VBCs.

Main Methods:

  • A Delphi study was conducted with patients, providers, payers, pharmacy benefits managers, and pharmaceutical company representatives.
  • Participants rated outcome importance and selected top meaningful outcomes; feasibility of data collection was also assessed.
  • Consensus was defined as ≥75% agreement.

Main Results:

  • "Preventing stroke or mini-stroke" achieved 100% agreement on importance and was selected as the most meaningful outcome by 81% of participants.
  • "Reducing hospitalizations" (97%), "preventing stroke or mini-stroke" (92%), and "reducing emergency department visits" (92%) were rated as most feasible.
  • Significant differences were observed in the selection of "improving health-related quality of life" as a most meaningful outcome between patient and non-patient groups.

Conclusions:

  • Findings will guide the design of AF value-based pharmaceutical contracts.
  • The study provides insights into stakeholder preferences for outcomes to improve AF care quality.